Font Size: a A A
Keyword [Plasminogen activator inhibitor type 1]
Result: 1 - 20 | Page: 1 of 2
1. Effects Of Plasminogen Activator Inhibitor Type-1 On Toll Like Receptor 4 Signaling Pathway In Acute Lung Injury Mice
2. Damage In Human Vascular Endothelial Cells By Tnf-¦Á Protective Effect Of Compound Danshen Active Monomer
3. The Correlated Research About The Factors Effecting Insulin Resistance
4. The Influence Of Rosiglitazone On The Metabolism And Reproduction Of Polycystic Ovarian Syndrome
5. The Relationship Between Plasma Concentrations Of TGF-β1 And PAI-1 With Atherosclerosis In Type 2 Diabetes Mellitus
6. The Relationship Between The Variations Of TM,VWF,PAI-1 And Essential Hypertension
7. Effects Of LPS And GLU On Secretion Of T-PA And PAI-1 From HUVEC In Vitro
8. The Change Of Coagulation And Fibrinolysis Related Factors Expression In HUVECs Infected With Dengue Virus 2
9. The Plasminogen Ability In Patients With Polycystic Ovary Syndrome And It's Clinical Significance
10. The Relationship Between The Single Nucleotide Polymorphism Of The Fibrinolytic Gene And Ischemic Stroke In Chinese
11. Clinical Investigation Of Hemostatic Parameters In The Course Of Hematopoietic Stem Cell Transplantation
12. Study Of The Levels And The Correlation About High Senstive C-reaction Protein And Plasminogen Activator Inhibitor Type 1 In Patients Of Unstable Angina Pectoris With 2 Type Diabetes Mellitus
13. Placental Expression Of T-PA And Its Inhibitor PAI-1 In The Patients Of Hypertensive Disorder Complicating Pregnancy
14. Regulator Of Endogenious PAI-1 Expression From Chinese Herb And Its Pharmacology
15. The Study On Plasminogen Activator Inhibitor Type 1 And High-sensitive C-reactive Protein In Metabolic Syndrome With Coronary Heart Disease
16. Effects Of Tongxinluo On VCAM-1 And PAI-1 Expression In Atherosclerotic Rabbits
17. The Study On The Correlation Between TNF-a NF-KBp65PAI-1Concentrations And The Pathogenesis Of The GDM
18. Insights into the dynamic structure and inhibitory mechanism of plasminogen activator inhibitor type 1
19. The transcriptional regulation of plasminogen activator inhibitor type 1 by transforming growth factor beta
20. Evaluation of 14-1B mutant of recombinant human plasminogen activator inhibitor type 1 (PAI-1) as a potential anti-angiogenic and anti-cancer agent
  <<First  <Prev  Next>  Last>>  Jump to